Tilman Gerlach

3.1k citations

25 papers · 2.4k indexed · h-index 19

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Epidemiology top 2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 22
- Hepatitis C virus research 21
Epidemiology 17
- Hepatitis B Virus Studies 14
- Liver Disease Diagnosis and Treatment 12

Co-authors: Gerd R. Pape Helmut M. Diepolder Roman Zachoval Thomas Berg Maria–Christina Jung Andreas Cerny Norbert H. Grüner Winfried Schraut
Journals: Hepatology (6 papers)Journal of Hepatology (4 papers)Vaccine (2 papers)European Journal of Gastroenterology & Hepatology (2 papers)Liver International (1 paper)
Partner nations: Germany Switzerland United States

In The Last Decade

Tilman Gerlach

25 papers receiving 2.4k citations

Peers

Countries citing papers authored by Tilman Gerlach

Since Specialization

Citations

This map shows the geographic impact of Tilman Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Gerlach more than expected).

Fields of papers citing papers by Tilman Gerlach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Gerlach. The network helps show where Tilman Gerlach may publish in the future.

Co-authors

The 25 scholars most cited alongside Tilman Gerlach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tilman Gerlach Line = papers co-authored together Tilman Gerlach links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon‐α and ribavirin in chronic hepatitis C virus patients Liver International ·Pascal Frei, Johannes H. Arendzen, Ulrike Held, Reto Kofmehl, Christine N. Manser, Johannes Schmitt, Joachim C. Mertens, Monika Rau, Daymí Godínez Caraballo, Tilman Gerlach, Francesco Negro, Markus H. Heim, Darius Moradpour, Andreas Cerny, Jean‐François Dufour, Beat Müllhaupt, Andreas Geier, (unknown)	2013	10
2	Prediction of minimal residual viremia in HCV type 1 infected patients receiving interferon-based therapy Annals of Hepatology ·Viola Knop, G Teuber, Hartwig Klinker, Bernd Möller, J. Rasenack, Holger Hinrichsen, Tilman Gerlach, Ulrich Spengler, Peter Buggisch, Konrad Neumann, Christoph Sarrazin, Stefan Zeuzem, Thomas Berg	2013	2
3	A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C PLoS ONE ·Christian M. Lange, Stéphanie Bibert, Zoltán Kutalik, Philippe Bürgisser, Andreas Cerny, Jean‐François Dufour, Andreas Geier, Tilman Gerlach, Markus H. Heim, Raffaele Malinverni, Francesco Negro, Stephan Regenass, Klaus Badenhoop, Jörg Bojunga, Christoph Sarrazin, Stefan Zeuzem, Tobias Müller, Thomas Berg, Pierre–Yves Bochud, Darius Moradpour, (unknown)	2012	47
4	The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection Journal of Gastroenterology ·V Weich, Eva Herrmann, Dietmar Geinitz, Christoph Sarrazin, Holger Hinrichsen, Peter Buggisch, Tilman Gerlach, Hartwig Klinker, Ulrich Spengler, A Bergk, Stefan Zeuzem, Thomas Berg	2011	22
5	Viral genotype-specific role of PNPLA3 , PPARG , MTTP, and IL28B in hepatitis C virus-associated steatosis Journal of Hepatology ·Tao Cai, Jean‐François Dufour, Beat Muellhaupt, Tilman Gerlach, Markus H. Heim, Darius Moradpour, Andreas Cerny, Raffaele Malinverni, Vincent Kaddai, Murielle Bochud, Francesco Negro, Pierre–Yves Bochud	2011	82
6	Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy Hepatology ·Christian M. Lange, Zoltán Kutalik, Kenichi Morikawa, Stéphanie Bibert, Andreas Cerny, G Dollenmaier, Jean‐François Dufour, Tilman Gerlach, Markus H. Heim, Raffaele Malinverni, Beat Müllhaupt, Francesco Negro, Darius Moradpour, Pierre–Yves Bochud	2011	39
7	Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany European Journal of Gastroenterology & Hepatology ·Charalabos‐Markos Dintsios, 直祐山脇, Johannes Wiegand, Tilman Gerlach, Heiner Wedemeyer, Gerd R. Pape, Michael P. Manns, Christian Krauth	2010	5
8	The Immunoregulatory Role of CD244 in Chronic Hepatitis B Infection and its Inhibitory Potential on Virus-Specific CD8+ T-cell Function Hepatology ·Bijan Raziorrouh, Winfried Schraut, Tilman Gerlach, SG Pujari, Norbert H. Grüner, Axel Ulsenheimer, Roman Zachoval, Martin Wächtler, Michael Spannagl, Jürgen Haas, Helmut M. Diepolder, Maria–Christina Jung	2010	180
9	Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1–infected patients†‡ Hepatology ·Thomas Berg, V Weich, G Teuber, Hartwig Klinker, Bernd Möller, J. Rasenack, Holger Hinrichsen, Tilman Gerlach, Ulrich Spengler, Peter Buggisch, Putri Rahimah Mughny, M Zankel, Konrad Neumann, Christoph Sarrazin, Stefan Zeuzem	2009	41
10	Antigen kinetics determines immune reactivity Proceedings of the National Academy of Sciences ·Pål Johansen, Tazio Storni, Lorna Rettig, Zhiyong Qiu, Matt Shields, Kevin M. Smith, Vania Manolova, Karl S. Lang, Gabriela Senti, Beat Müllhaupt, Tilman Gerlach, Roberto F. Speck, Adrian Bot, Thomas M. Kündig	2008	149
11	Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-α and ribavirin: results from a randomized, placebo-controlled, double-blind trial European Journal of Gastroenterology & Hepatology ·Bernd Kronenberger, Thomas Berg, Eva Herrmann, Holger Hinrichsen, Tilman Gerlach, Peter Buggisch, Ulrich Spengler, Tobias Goeser, Samer Nasser, Karsten Wursthorn, Gerd R. Pape, U. Hopf, Stefan Zeuzem	2007	15
12	Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG‐PET‐CT Journal of Clinical Ultrasound ·Stephan M. Wildi, Christoph Gubler, Thomas F. Hany, Henrik Petrowsky, Pierre A. Clavien, Wolfram Jochum, Tilman Gerlach, Michael Fried, Beat Müllhaupt	2007	34
13	Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine Vaccine ·Norbert H. Gruener, Tilman Gerlach, Axel Ulsenheimer, Helmut M. Diepolder, Eddy A. Wierenga, Roman Zachoval, Malte Heeg, Gerd R. Pape, Maria–Christina Jung	2006	2
14	Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin Gastroenterology ·Thomas Berg, Michael Wagner, Samer Nasser, Christoph Sarrazin, Tobias Heintges, Tilman Gerlach, Peter Buggisch, Tobias Goeser, J. Rasenack, Gerd R. Pape, Wolfgang E. Schmidt, B. Kallinowski, Hartwig Klinker, Ulrich Spengler, Peter Martus, U. Alshüth, Stefan Zeuzem	2006	368
15	Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy Hepatology ·Thomas Berg, Krissa Marie Japco, Eva Herrmann, Holger Hinrichsen, Tilman Gerlach, Roman Zachoval, Bertram Wiedenmann, U. Hopf, S Zeuzem	2003	221
16	Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response Journal of Hepatology ·Norbert H. Gruener, Maria–Christina Jung, Axel Ulsenheimer, Tilman Gerlach, Helmut M. Diepolder, Carl Albrecht Schirren, Robert M. Hoffmann, Martin Wächtler, Markus Backmund, Gerd R. Pape	2002	27
17	Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers Vaccine ·Maria–Christina Jung, Norbert H. Grüner, Roman Zachoval, Winfried Schraut, Tilman Gerlach, Helmut M. Diepolder, C. Rohner, Mark Page, A.M. Bakyt, Yu.I. Lazovsky, E. Douglas Whitehead, Jörg Trojan, Stefan Zeuzem, Gerd R. Pape	2002	55
18	Vigorous Peripheral Blood Cytotoxic T Cell Response during the Acute Phase of Hepatitis C Virus Infection Cellular Immunology ·Magali Cucchiarini, Andreas R. Kammer, Benno Grabscheid, Helmut M. Diepolder, Tilman Gerlach, Norbert H. Grüner, Teresa Santantonio, Jürg Reichen, Gerd R. Pape, Andreas Cerny	2000	72
19	Association of Hepatitis C Virus–Specific CD8⁺T Cells with Viral Clearance in Acute Hepatitis C The Journal of Infectious Diseases ·Norbert H. Grüner, Tilman Gerlach, Else Toller, Helmut M. Diepolder, Carl Albrecht Schirren, Winfried Schraut, Robert M. Hoffmann, Roman Zachoval, Teresa Santantonio, Magali Cucchiarini, Andreas Cerny, Gerd R. Pape	2000	308
20	Antibodies Against Hepatitis C Virus-Like Particles and Viral Clearance in Acute and Chronic Hepatitis C Hepatology ·Thomas F. Baumert, C.G. Bologa, Pauline Gouttefarde, Jujin Satoi, David Herion, Tilman Gerlach, Gerd R. Pape, Johnson Y.N. Lau, Yasmine Nahed, Hubert E. Blum, Jake T. Liang	2000	64

About Tilman Gerlach

Tilman Gerlach is a scholar working on Hepatology, Epidemiology, Immunology, Virology and Speech and Hearing, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (14 papers), Liver Disease Diagnosis and Treatment (12 papers), Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers), T-cell and B-cell Immunology (3 papers), Viral gastroenteritis research and epidemiology (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (1.6k citations), Virology (161 citations), Immunology (689 citations) and Rheumatology (250 citations). Tilman Gerlach has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Gerd R. Pape, Helmut M. Diepolder, Roman Zachoval, Thomas Berg, Maria–Christina Jung, Andreas Cerny, Norbert H. Grüner, Winfried Schraut, Norbert H. Gruener and Holger Hinrichsen. Their work appears in journals such as Hepatology, Journal of Hepatology, Vaccine, European Journal of Gastroenterology & Hepatology and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact